{"id":"W3121895660","doi":"10.1200/jco.2021.39.3_suppl.tps145","title":"BOLD-100-001 (TRIO039): A phase Ib dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid tumors.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Translational Research in Oncology; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Ottawa Hospital; McGill University; McMaster University; Alberta Health Services","funders":"","keywords":"FOLFOX; Medicine; Tolerability; Oncology; Internal medicine; Chemotherapy; Colorectal cancer; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Combination therapy; Cancer; Oxaliplatin; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230885,0.001785489,0.001556986,0.0007353944,0.0003850469,0.001063315,0.001106525,0.00140075,0.003388793],"category_scores_gemma":[0.0006061167,0.0006461731,0.001176395,0.0005291646,0.0008520675,0.0007592739,0.0004505109,0.003311141,0.001050535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001092466,"about_ca_system_score_gemma":0.001704336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001399651,"about_ca_topic_score_gemma":0.003325715,"domain_scores_codex":[0.9996617,0.0001392395,0.00001859528,0.00005047938,0.00003959796,0.00009048414],"domain_scores_gemma":[0.9993904,0.00006855842,0.0001054833,0.00004873231,0.00003502997,0.000351836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4728172,0.2205144,0.007330182,0.001445055,0.001357218,0.0005067755,0.0006490813,0.005597013,0.1073903,0.0006825929,0.009081904,0.1726283],"study_design_scores_gemma":[0.3351505,0.6420655,0.009205986,0.00004833257,0.0002874071,0.0003598126,0.0000801089,0.001661834,0.007189102,0.000199138,0.003709239,0.00004307775],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903553,0.00171296,0.0005361816,0.000569282,0.0001085083,0.003007472,0.00114982,0.0002026806,0.00235787],"genre_scores_gemma":[0.9826246,0.002135311,0.002619355,0.001310158,0.0001151364,0.003084583,0.003578808,0.00005390405,0.004478238],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003388793,"threshold_uncertainty_score":0.01133662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03731174198347995,"score_gpt":0.4351419497730816,"score_spread":0.3978302077896017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}